To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?

dc.contributor.author	Aydin, S.
dc.contributor.author	Sahin, I.
dc.contributor.author	Demirel, U.
dc.contributor.author	Aksoy, A.
dc.date.accessioned	2021-12-16T10:13:12Z
dc.date.available	2021-12-16T10:13:12Z
dc.date.issued	2011
dc.identifier.issn	260495
dc.identifier.uri	https://doi.org/10.1016/j.metabol.2011.01.015
dc.identifier.uri	http://dspace.beu.edu.tr:8080/xmlui/handle/20.500.12643/13453
dc.description.abstract	[No abstract available]
dc.language.iso	English
dc.source	Metabolism: Clinical and Experimental
dc.title	To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
dc.type	Letter
dc.identifier.issue	7
dc.identifier.doi	10.1016/j.metabol.2011.01.015
dc.identifier.scopus	2-s2.0-79959357939
dc.identifier.volume	60

Files in this item

Files	Size	Format	View
There are no files associated with this item.